Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:3-oxocyclopentanecarbonitrile
go back to main search page
Accession:CHEBI:71188 term browser browse the term
Definition:An alicyclic ketone that is cyclopentanone substituted at position 3 by a cyano group.
Synonyms:related_synonym: 3-cyanocyclopentanone;   3-ketocyclopentanecarbonitrile;   Formula=C6H7NO;   InChI=1S/C6H7NO/c7-4-5-1-2-6(8)3-5/h5H,1-3H2;   InChIKey=RJDDBRGASHENKL-UHFFFAOYSA-N;   SMILES=O=C1CCC(C1)C#N
 xref: CAS:41171-91-9;   Reaxys:2637152


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 0
    chemical entity 0
      group 0
        pseudohalo group 0
          cyano group 0
            nitrile 0
              aliphatic nitrile 0
                3-oxocyclopentanecarbonitrile 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 0
    subatomic particle 0
      composite particle 0
        hadron 0
          baryon 0
            nucleon 0
              atomic nucleus 0
                atom 0
                  main group element atom 0
                    p-block element atom 0
                      carbon group element atom 0
                        carbon atom 0
                          organic molecular entity 0
                            organic group 0
                              organic divalent group 0
                                organodiyl group 0
                                  carbonyl group 0
                                    carbonyl compound 0
                                      ketone 0
                                        cyclic ketone 0
                                          alicyclic ketone 0
                                            3-oxocyclopentanecarbonitrile 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.